4//SEC Filing
GENENCOR INTERNATIONAL INC 4
Accession 0000891839-05-000034
CIK 0001113099operating
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 2:03 PM ET
Size
17.3 KB
Accession
0000891839-05-000034
Insider Transaction Report
Form 4
GOLDSMITH MARK A
Sr. VP Health Care
Transactions
- Disposition from Tender
Stock Option (Right to Buy)
2005-04-21−60,000→ 0 totalExercise: $11.73→ Common Stock, par value $.01 per share (60,000 underlying) - Disposition from Tender
Stock Option (Right to Buy)
2005-04-21−85,000→ 0 totalExercise: $14.52→ Common Stock, par value $.01 per share (85,000 underlying) - Disposition from Tender
Common Stock, $.01 par value
2005-04-20$19.25/sh−1,308$25,179→ 0 total(indirect: By Trust) - Disposition from Tender
Stock Option (Right to Buy)
2005-04-21−50,000→ 0 totalExercise: $16.23→ Common Stock, par value $.01 per share (50,000 underlying) - Will/Inheritance
Common Stock, $.01 par value
2005-02-09+1,308→ 1,308 total(indirect: By Trust) - Disposition from Tender
Stock Option (Right to Buy)
2005-04-21−30,000→ 0 totalExercise: $10.09→ Common Stock, par value $.01 per share (30,000 underlying)
Footnotes (3)
- [F1]On 02/09/05, upon the death of the previous beneficial owner, Dr. Goldsmith acquired beneficial ownership of these shares as successor trustee and one-third beneficiary of a trust that held 1,308 shares of Genencor International, Inc. common stock.
- [F2]On 1/27/05, Genencor International, Inc. (the "Company"), Danisco A/S ("Danisco") and DH Subsidiary Inc., an indirect wholly-owned subsidiary of Danisco ("Acquisition Sub") entered into an Acquisition Agreement (the "Acquisition Agreement") providing for a cash tender offer to acquire all of the outstanding shares of common stock of the Company not otherwise owned by Danisco or its subsidiaries for $19.25 per share, to be followed by a merger of Acquisition Sub with and into the Company, with the Company to continue as the surviving corporation. These shares were accepted in the closing of the tender offer on 4/20/05.
- [F3]Pursuant to the terms of the Acquisition Agreement, as of the effective time of the merger (5:00 PM EST on 4/21/05), these options will be cancelled and Dr. Goldsmith will be entitled to receive a cash payment in an amount equal to the difference between $19.25 (for options issued under the Company's Stock Option and Stock Appreciation Right Plan) or $19.27 (for options issued under the Company's 2002 Omnibus Incentive Plan) and the exercise price per share under the option multiplied by the number of shares covered by the option.
Documents
Issuer
GENENCOR INTERNATIONAL INC
CIK 0001113099
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001113099
Filing Metadata
- Form type
- 4
- Filed
- Apr 21, 8:00 PM ET
- Accepted
- Apr 22, 2:03 PM ET
- Size
- 17.3 KB